ZFYVE19 Antibodies

Santa Cruz Biotechnology delivers a wide array of ZFYVE19 monoclonal antibodies for research applications. ZFYVE19 monoclonal antibodies are compatible with multiple experimental techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). ZFYVE19, also known as Zinc Finger, FYVE Domain Containing 19, plays a central role in cellular processes such as endocytosis and membrane trafficking. ZFYVE19's involvement in cellular pathways is essential for maintaining cellular homeostasis and regulating signal transduction. Research focused on ZFYVE19 continues to reveal new insights into various diseases, including cancer and neurodegenerative disorders. Investigating ZFYVE19's molecular mechanisms and interactions can lead to better understanding of disease progression and potential therapeutic targets. Advanced research techniques using ZFYVE19 monoclonal antibodies enable precise detection and analysis of protein expression patterns. Ongoing studies of ZFYVE19 contribute to expanding scientific knowledge about cellular regulation and disease mechanisms. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of ZFYVE19's role in health and disease.